Single-dose palonosetron for prevention of chemotherapy-induced nausea and vomiting in patients with aggressive non-Hodgkin's lymphoma receiving moderately emetogenic chemotherapy containing steroids: results of a phase II study from the Gruppo Italiano per lo Studio dei Linfomi (GISL)

PURPOSE: The control of nausea and vomiting induced by chemotherapy is paramount for overall treatment success in cancer patients. Antiemetic therapy during chemotherapy in lymphoma patients generally consists of anti-serotoninergic drugs and dexamethasone. The aim of this trial was to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Renzo, Nicola, Montanini, Antonella, Mannina, Donato, Dondi, Alessandra, Muci, Stefania, Mancuso, Salvatrice, De Paolis, M. Rosaria, Plati, Caterina, Stelitano, Caterina, Patti, Catia, Olivieri, Attilio, Liardo, Eliana, Buda, Gabriele, Cantaffa, Renato, Federico, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166604/
https://www.ncbi.nlm.nih.gov/pubmed/20694798
http://dx.doi.org/10.1007/s00520-010-0974-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3166604/
https://www.ncbi.nlm.nih.gov/pubmed/20694798
http://dx.doi.org/10.1007/s00520-010-0974-y

Ejemplares similares